Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo
- PMID: 12200148
- DOI: 10.1016/s0006-291x(02)02013-2
Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo
Abstract
Efficiencies of a nuclease resistant antisense oligonucleotide and of siRNA both being targeted against the green fluorescent protein stably expressed in HeLa cells are compared in cell cultures and in xenografted mice. Using Cytofectin GSV to deliver both inhibitors, the siRNAs appear to be quantitatively more efficient and its effect is lasting for a longer time in cell culture. In mice, we observed an activity of siRNAs but not of antisense oligonucleotides. The absence of efficiency of antisense oligonucleotides is probably due to their lower resistance to nuclease degradation.
Similar articles
-
Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA.Nucleic Acids Res. 2003 Jun 15;31(12):3185-93. doi: 10.1093/nar/gkg409. Nucleic Acids Res. 2003. PMID: 12799446 Free PMC article.
-
Cellular dynamics of antisense oligonucleotides and short interfering RNAs.Ann N Y Acad Sci. 2006 Oct;1082:47-51. doi: 10.1196/annals.1348.061. Ann N Y Acad Sci. 2006. PMID: 17145924
-
Central administration of small interfering RNAs in rats: a comparison with antisense oligonucleotides.Eur J Pharmacol. 2005 Oct 17;522(1-3):30-7. doi: 10.1016/j.ejphar.2005.08.021. Epub 2005 Oct 6. Eur J Pharmacol. 2005. PMID: 16213482
-
Polyamine-oligonucleotide conjugates: a promising direction for nucleic acid tools and therapeutics.Future Med Chem. 2015;7(13):1733-49. doi: 10.4155/fmc.15.90. Epub 2015 Oct 1. Future Med Chem. 2015. PMID: 26424049 Review.
-
Antisense inhibition: oligonucleotides, ribozymes, and siRNAs.Methods Mol Med. 2005;106:11-34. Methods Mol Med. 2005. PMID: 15375310 Review. No abstract available.
Cited by
-
Novel antihypertensive agents for resistant hypertension: what does the future hold?Hypertens Res. 2022 Dec;45(12):1918-1928. doi: 10.1038/s41440-022-01025-9. Epub 2022 Sep 27. Hypertens Res. 2022. PMID: 36167808 Review.
-
Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.Front Genet. 2012 Aug 20;3:154. doi: 10.3389/fgene.2012.00154. eCollection 2012. Front Genet. 2012. PMID: 22934103 Free PMC article.
-
The therapeutic potential of RNA interference.FEBS Lett. 2005 Oct 31;579(26):5996-6007. doi: 10.1016/j.febslet.2005.08.004. Epub 2005 Aug 15. FEBS Lett. 2005. PMID: 16115631 Free PMC article. Review.
-
Progress towards in vivo use of siRNAs.Mol Ther. 2006 Apr;13(4):644-70. doi: 10.1016/j.ymthe.2006.01.001. Epub 2006 Feb 14. Mol Ther. 2006. PMID: 16481219 Free PMC article. Review.
-
RNA interference: ready to silence cancer?J Mol Med (Berl). 2006 Jan;84(1):4-15. doi: 10.1007/s00109-005-0709-6. Epub 2005 Nov 9. J Mol Med (Berl). 2006. PMID: 16283143 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources